Adpaxil 30 mg(Paclitaxel Injection) Adpaxil 30 mg(Paclitaxel Injection) Adpaxil 30 mg(Paclitaxel Injection)

Adpaxil 30 mg(Paclitaxel Injection)

1085 INR/Box

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Anti-Cancer
  • Dosage 30 mg
  • Supply Ability : 10000 Box Per Week
  • Click to view more
X

Price And Quantity

  • 1085 INR/Box
  • 1 Box

Product Specifications

  • 30 mg
  • Anti-Cancer
  • Liquid
  • Injection

Trade Information

  • Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 10000 Box Per Week
  • 15-20 Days
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

 

Productname : Adpaxil 30 mg

GenericName : Paclitaxel Injection

Manufacturer : Adley

 

Adpaxil belongs to the group of medicinescalled antineoplastics. It interferes with the growth of cancer cells, whichare eventually destroyed. Since the growth of normal body cells may also beaffected, other unwanted effects will also occur. Some of these may be seriousand must be reported to your doctor. Other effects may not be serious but maycause concern. Some effects may not occur until months or years after themedicine is used.

HOWSHOULD I USE ADPAXIL?

Use Adpaxil as directed by your doctor. Check the label on themedicine for exact dosing instructions.

USESOF ADPAXIL IN DETAILS

Adpaxil is used alone or in combination withother chemotherapeutic agents in the treatment of ovarian cancer, breastcancer, advanced non-small cell lung cancer, cancer of pancreas, and AIDSrelated Kaposi’s sarcoma (a type of cancer that develops from the cells thatline lymph or blood vessels).

ADPAXILINTERACTIONS

Ketoconazole: As ketoconazole may inhibit the metabolism of Adpaxil,patients receiving Adpaxil and ketoconazole should be closely monitored or thecombination of these drugs should be avoided.

ADPAXILSIDE EFFECTS

Hematologic: Bonemarrow suppression was the major dose-limiting toxicity of Adpaxil.Neutropenia, the most important hematologic toxicity, was dose- andschedule-dependent and was generally rapidly reversible. Among patients treatedin phase 3 second-line ovarian study with a 3-hr infusion, neutrophil countsdeclined <500 cells/mm3 in 14% of patients treated with adose of 135 mg/m2compared to 27% at a dose of 175 mg/m(p=0.05).

 

 


VEA IMPEX

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



"We mainly deliver our products to the foreign countries."
Back to top